Table 3 Demographic data, sexual function, gynecological evaluation, Pap smears, genital infections and HPV vaccination and disease parameters in juvenile idiopathic arthritis (JIA) patients with abnormal and normal cervical cytology

 Current age, years

26.2 ± 6.3

23.5 ± 6.3

0.730

 Disease duration, years

13.5 ± 6.6

15.9 ± 7.5

0.427

 Caucasian

4 (50)

16 (64)

0.681

 Upper middle and lower middle SE class

8 (100)

24 (96)

1.000

 Vaginal discharge

4 (50)

6 (24)

0.205

 Sexual activity

7 (87)

18 (72)

0.649

 First sexual activity age, years

19.5 (15–22)

17 (14–30)

0.779

 Sexual intercourse in last month

4 (50)

15 (60)

0.695

 Sexual intercourse in last month, number

1 (0–12)

2.5 (0–15)

0.85

 Sexual intercourse in last year

6 (75)

17 (68)

1.000

 Sexual intercourse in last year, number

12 (0–144)

20 (0–180)

0.813

 Sexual partner in last month, number

1 (0–1)

1 (0–1)

0.849

 Sexual partner in last year, number

1 (0–1)

1 (0–2)

0.776

 Gardnerella vaginalis

1 (12)

3 (12)

1.000

 Candida sp.

0 (0)

0 (0)

1.000

 Trichomonas vaginallis

0 (0)

0 (0)

1.000

 Chlamydia trachomatis

0 (0)

0 (0)

1.000

 Neisseria gonorrhoeae

0 (0)

0 (0)

1.000

 Human Papillomavirus (HPV)

7 (87)

3 (12)

Previous quadrivalent HPV vaccination

0 (0)

2 (8)

1.000

 JADAS 71 (0–101)

0

2 (0–5)

NA

 DAS28 (0–7)

4.5 (1.36–2.66)

5.0 (1.05–5.21)

0.674

 Number of active joints

0 (0–3)

1 (0–12)

0.514

 Number of limited joints

1.5 (0–43)

5 (0–39)

0.425

 Patient global VAS (0–10)

1.5 (0–8)

2 (0–9)

0.705

 Physician global VAS (0–10)

0 (0–2)

1 (0–5)

0.344

 ESR, mm/1st hour

12.8 ± 5.4

9.7 ± 6.9

0.268

 CRP, mg/L

3.7 (0.4–77)

1.8 (0.2–14)

0.257